• Je něco špatně v tomto záznamu ?

Overexpression of CD44v8-10 in Colon Polyps-A Possible Key to Early Diagnosis

M. Dastych, F. Hubatka, P. Turanek-Knotigova, J. Masek, R. Kroupa, M. Raška, J. Turanek, L. Prochazka

. 2021 ; 27 (-) : 614281. [pub] 20210330

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012502

Background and aims: The majority of colorectal cancers arise from detectable adenomatous or serrated lesions. Here we demonstrate how deregulated alternative splicing of CD44 gene in diseased colon mucosa results in downregulation of standard isoform of CD44 gene (CD44s) and upregulation of variant isoform CD44v8-10. Our aim is to show that upregulation of CD44v8-10 isoform is a possible marker of precancerous lesion in human colon. Methods: We analysed pairs of fresh biopsy specimen of large intestine in a cohort of 50 patients. We studied and compared alternative splicing profile of CD44 gene in colon polyps and adjoined healthy colon mucosa. We performed end-point and qRT PCR, western blotting, IHC staining and flow cytometry analyses. Results: We detected more than five-fold overexpression of CD44v8-10 isoform and almost twenty-fold downregulation of standard isoform CD44s in colon polyps compared to adjoined healthy tissue with p = 0.018 and p < 0.001 in a cohort of 50 patients. Our results also show that aberrant splicing of CD44 occurs in both biologically distinct subtypes of colorectal adenoma possibly in ESRP-1 specific manner. Conclusion: 92% of the colon polyp positive patients overexpressed CD44v8-10 isoform in their colon polyps while only 36% of them had positive fecal occult blood test which is currently a standard non-invasive screening technique. Impact: We believe that our results are important for further steps leading to application of CD44v8-10 isoform as a biomarker of colorectal precancerosis in non-invasive detection. Early detection of colon precancerosis means successful prevention of colorectal carcinoma.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012502
003      
CZ-PrNML
005      
20220506131034.0
007      
ta
008      
220425s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/pore.2021.614281 $2 doi
035    __
$a (PubMed)34257584
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dastych, Milan $u Department of Gastroenterology and Internal Medicine, University Hospital Brno and Faculty of Medicine Masaryk University Brno, Brno, Czech Republic
245    10
$a Overexpression of CD44v8-10 in Colon Polyps-A Possible Key to Early Diagnosis / $c M. Dastych, F. Hubatka, P. Turanek-Knotigova, J. Masek, R. Kroupa, M. Raška, J. Turanek, L. Prochazka
520    9_
$a Background and aims: The majority of colorectal cancers arise from detectable adenomatous or serrated lesions. Here we demonstrate how deregulated alternative splicing of CD44 gene in diseased colon mucosa results in downregulation of standard isoform of CD44 gene (CD44s) and upregulation of variant isoform CD44v8-10. Our aim is to show that upregulation of CD44v8-10 isoform is a possible marker of precancerous lesion in human colon. Methods: We analysed pairs of fresh biopsy specimen of large intestine in a cohort of 50 patients. We studied and compared alternative splicing profile of CD44 gene in colon polyps and adjoined healthy colon mucosa. We performed end-point and qRT PCR, western blotting, IHC staining and flow cytometry analyses. Results: We detected more than five-fold overexpression of CD44v8-10 isoform and almost twenty-fold downregulation of standard isoform CD44s in colon polyps compared to adjoined healthy tissue with p = 0.018 and p < 0.001 in a cohort of 50 patients. Our results also show that aberrant splicing of CD44 occurs in both biologically distinct subtypes of colorectal adenoma possibly in ESRP-1 specific manner. Conclusion: 92% of the colon polyp positive patients overexpressed CD44v8-10 isoform in their colon polyps while only 36% of them had positive fecal occult blood test which is currently a standard non-invasive screening technique. Impact: We believe that our results are important for further steps leading to application of CD44v8-10 isoform as a biomarker of colorectal precancerosis in non-invasive detection. Early detection of colon precancerosis means successful prevention of colorectal carcinoma.
650    _2
$a nádorové biomarkery $x genetika $x metabolismus $7 D014408
650    _2
$a kolon $x metabolismus $x patologie $7 D003106
650    _2
$a polypy tlustého střeva $x metabolismus $x patologie $7 D003111
650    _2
$a kolorektální nádory $x diagnóza $x genetika $x metabolismus $7 D015179
650    _2
$a lidé $7 D006801
650    _2
$a antigeny CD44 $x genetika $x metabolismus $7 D018960
650    _2
$a prognóza $7 D011379
650    _2
$a protein - isoformy $7 D020033
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hubatka, Frantisek $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic $u C2P NEXARS, Campus Science Park, Brno, Czech Republic
700    1_
$a Turanek-Knotigova, Pavlina $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic $u C2P NEXARS, Campus Science Park, Brno, Czech Republic
700    1_
$a Masek, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Kroupa, Radek $u Department of Gastroenterology and Internal Medicine, University Hospital Brno and Faculty of Medicine Masaryk University Brno, Brno, Czech Republic
700    1_
$a Raška, Milan $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Turanek, Jaroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic $u C2P NEXARS, Campus Science Park, Brno, Czech Republic $u Faculty of Medicine in Hradec Kralove, Institute of Hygiene and Preventive Medicine, Charles University, Hradec Kralove, Czech Republic $u Institute of Physics of the Czech Academy of Sciences, Prague 8, Czech Republic
700    1_
$a Prochazka, Lubomir $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
773    0_
$w MED00180530 $t Pathology oncology research : POR $x 1532-2807 $g Roč. 27, č. - (2021), s. 614281
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34257584 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131027 $b ABA008
999    __
$a ok $b bmc $g 1789908 $s 1163703
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 27 $c - $d 614281 $e 20210330 $i 1532-2807 $m Pathology oncology research $n Pathol Oncol Res $x MED00180530
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace